Holen Sie sich die Stockscreener-App
0.9776
24.22%
0.1906
Handel nachbörslich:
.96
-0.0176
-1.80%
Schlusskurs vom Vortag:
$0.787
Offen:
$0.819
24-Stunden-Volumen:
968.75K
Relative Volume:
1.23
Marktkapitalisierung:
$126.64M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-35.47M
KGV:
-1.7151
EPS:
-0.57
Netto-Cashflow:
$-124.27M
1W Leistung:
+35.25%
1M Leistung:
+41.68%
6M Leistung:
-52.77%
1J Leistung:
-72.84%
1-Tages-Spanne:
$0.8008
$0.9801
1-Wochen-Bereich:
$0.7082
$0.9801
52-Wochen-Spanne:
$0.4603
$3.60
Prokidney Corp Stock (PROK) Company Profile
Firmenname
Prokidney Corp
Sektor
Branche
Telefon
336-999-7028
Adresse
2000 FRONTIS PLAZA BLVD., WINSTON-SALEM
Vergleichen Sie PROK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PROK
Prokidney Corp
|
0.9776 | 93.33M | 0 | -35.47M | -124.27M | -0.57 |
|
ONC
Beone Medicines Ltd Adr
|
255.86 | 26.69B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
450.50 | 114.81B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.232 | 41.83M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
84.34 | 6.60B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
493.22 | 65.36B | 14.09B | 4.50B | 2.96B | 39.28 |
Prokidney Corp Stock (PROK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-09-30 | Eingeleitet | JP Morgan | Neutral |
| 2024-09-10 | Eingeleitet | Guggenheim | Buy |
| 2024-03-07 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-01-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-07-25 | Eingeleitet | BTIG Research | Buy |
| 2022-12-21 | Eingeleitet | Jefferies | Buy |
| 2022-11-10 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-10-18 | Eingeleitet | UBS | Buy |
| 2022-10-14 | Eingeleitet | Citigroup | Buy |
| 2022-09-23 | Eingeleitet | BofA Securities | Buy |
| 2022-09-02 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Prokidney Corp Aktie (PROK) Neueste Nachrichten
Nuveen Asset Management LLC Buys 39,216 Shares of ProKidney Corp. (NASDAQ:PROK) - Defense World
BNP Paribas Financial Markets Invests $110,000 in ProKidney Corp. (NASDAQ:PROK) - Defense World
ProKidney Approves Key Proposals at Annual Meeting - TipRanks
Northern Trust Corp Has $1.51 Million Position in ProKidney Corp. (NASDAQ:PROK) - Defense World
ProKidney quarterly loss grows as it nears two key milestones - Winston-Salem Journal
ProKidney Up 26%, Insiders Still In The Red By US$35m - simplywall.st
Wells Fargo & Company MN Purchases 18,431 Shares of ProKidney Corp. (NASDAQ:PROK) - Defense World
ProKidney (PROK) Eyes Key Developments and Strong Financial Outl - GuruFocus
ProKidney Corp. Reports Increased Losses Amid Ongoing R&D - TipRanks
ProKidney (PROK) Eyes Key Developments and Strong Financial Outlook | PROK Stock News - GuruFocus
PROKIDNEY CORP. SEC 10-Q Report - TradingView
ProKidney Reports First Quarter 2025 Financial Results and Business Highlights - The Manila Times
ProKidney Corp. (NASDAQ:PROK) Shares Bought by Barclays PLC - Defense World
Mariner LLC Has $64,000 Stake in ProKidney Corp. (NASDAQ:PROK) - The AM Reporter
Mariner LLC Sells 15,937 Shares of ProKidney Corp. (NASDAQ:PROK) - Defense World
PROKIDNEY Earnings Preview: Recent $PROK Insider Trading, Hedge Fund Activity, and More - Nasdaq
ProKidney Corp. (NASDAQ:PROK) Shares Bought by Renaissance Technologies LLC - Defense World
JPMorgan Chase & Co. Buys 19,585 Shares of ProKidney Corp. (NASDAQ:PROK) - Defense World
ProKidney (PROK) Expected to Announce Quarterly Earnings on Friday - Defense World
The ProKidney Corp (PROK) had a good session last reading, didn’t it? - uspostnews.com
ProKidney Corp (PROK) receives a Neutral rating from JP Morgan - knoxdaily.com
ProKidney Corp Inc. (PROK) Price Performance: The Role of Supply and Demand - investchronicle.com
Gaining Ground: ProKidney Corp (PROK) Closes Higher at 1.08, Up 4.85 - DWinneX
Geode Capital Management LLC Grows Stock Position in ProKidney Corp. (NASDAQ:PROK) - Defense World
Is ProKidney Corp (PROK) positioned for future growth? - Sete News
ProKidney Corp (NASDAQ:PROK)’s 12-Month Price Target Currently Stands At 6 - Marketing Sentinel
Major Investment Alert: Carso De-C Inmobiliaria Acquires ProKidney Shares! - TipRanks
ProKidney Corp [PROK] Records 50-Day SMA of $1.0283 - knoxdaily.com
The Psychology of ProKidney Corp Inc. (PROK) Price Performance: Understanding Market Sentiment - investchronicle.com
Analytical Overview: ProKidney Corp (PROK)’s Ratios Tell a Financial Story - DWinneX
Major Investment Alert: ProKidney Stock Sees New Stakeholder! - TipRanks
Major Investment Alert: ProKidney Stock Acquisition! - TipRanks
Major Investment Alert: ProKidney Stock Sees Significant Purchase! - TipRanks
Greensboro’s Once Great Win Is Now A ProKidney Failure - Rhino Times
Major Investment Alert: ProKidney Stock Sees Big Buy-In! - TipRanks
Control empresarial de capitales purchases $628,847 in ProKidney shares - Investing.com
Control empresarial de capitales purchases $628,847 in ProKidney shares By Investing.com - Investing.com Canada
Sei Investments Co. Makes New $69,000 Investment in ProKidney Corp. (NASDAQ:PROK) - Defense World
Critical Review: Candel Therapeutics (NASDAQ:CADL) & ProKidney (NASDAQ:PROK) - Defense World
PROK stock touches 52-week low at $0.49 amid market challenges - Investing.com India
Institutional owners may take dramatic actions as ProKidney Corp.'s (NASDAQ:PROK) recent 32% drop adds to one-year losses - simplywall.st
Bank of New York Mellon Corp Has $388,000 Holdings in ProKidney Corp. (NASDAQ:PROK) - Defense World
Here's Why We're Watching ProKidney's (NASDAQ:PROK) Cash Burn Situation - Yahoo Finance
Down -38% in 4 Weeks, Here's Why You Should You Buy the Dip in PROKIDNEY CP (PROK) - Yahoo Finance
PROK stock touches 52-week low at $0.94 amid market challenges - Investing.com India
ProKidney Corp reports results for the quarter ended December 31Earnings Summary - TradingView
ProKidney Hold Rating: Balancing Developmental Progress and Financial Stability Amid Uncertainty - TipRanks
ProKidney Corp (PROK) Reports $163.3 Million Net Loss for 2024, - GuruFocus.com
Finanzdaten der Prokidney Corp-Aktie (PROK)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.00%
2.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):